Myeloma diagnosis and management (Diagnosis and management of myeloma (multiple myeloma))

What is myeloma diagnosis and management?

Myeloma (also called multiple myeloma) is a cancer of plasma cells, a type of white blood cell made in the bone marrow. Abnormal plasma cells build up in the marrow and produce an abnormal protein (a paraprotein), which can damage the bones, kidneys and blood and lower the body's ability to fight infection.

Diagnosis and management means confirming the diagnosis, assessing how active the myeloma is and what damage it has caused, and planning treatment and supportive care. Myeloma is often picked up through blood or urine tests showing a paraprotein, anaemia, kidney problems or raised calcium, or through bone pain or a fracture.

Myeloma is a relapsing and remitting condition. This means treatment can control it well and bring periods of remission, but it tends to come back over time, when further treatment is given. There has been real progress in treatment, and many people live well for years.

It is important to be honest: for most people, myeloma is treatable but not currently curable. The aim of treatment is to control the disease, relieve symptoms, prevent and treat complications, and maintain a good quality of life for as long as possible. A related, earlier condition called smouldering myeloma, and a non-cancerous finding called MGUS, are usually monitored rather than treated. Care is led by a specialist blood-cancer team (a multidisciplinary team, or MDT), who will explain what treatment is aiming to achieve in your case.

Types, options & approaches

There may be different ways to do this. The right approach depends on the clinical question and your circumstances.

Myeloma and related findings

Your team decides where you fit and what is needed. Treatment aims to control active myeloma, not cure it, for most people.

Preparing for your treatment

• Bring all blood and urine results, scans and any bone marrow reports.
• Note your symptoms and when they began, such as bone pain, tiredness, frequent infections, thirst or foamy urine.
• List all medicines and supplements, and any other conditions, especially kidney problems.
• Mention any recent fractures or persistent back or bone pain.
• Write down your questions, and consider bringing someone with you, as a lot is discussed.
• Ask what tests to expect, including a bone marrow test and bone imaging.
• Make sure your specialist team and GP can share information, especially if any care is private.
• Ask about staying well hydrated and protecting your kidneys, as advised by your team.

What happens

Diagnosis usually starts with blood and urine tests, often prompted by anaemia, kidney problems, raised calcium, bone pain or an abnormal protein found on testing. Tests look for the paraprotein and free light chains. If myeloma is suspected, you are referred to a haematology team.

The diagnosis is confirmed with a bone marrow test, taken under local anaesthetic, which shows the abnormal plasma cells. Imaging of the bones — often a whole-body scan such as CT, MRI or PET/CT — looks for areas of damage. Together these tests confirm myeloma, distinguish it from MGUS or smouldering myeloma, and assess its effects on the body.

Your case is discussed by a specialist blood-cancer team (MDT). Treatment for active myeloma usually combines several anti-myeloma medicines, sometimes followed by a stem cell transplant using your own stem cells for suitable people. Alongside this, supportive care protects the bones (for example with bone-strengthening medicines), looks after the kidneys, treats anaemia and reduces infection risk. Throughout, you should be told what the treatment is aiming to achieve.

Is this treatment right for me?

A good consultation should explore whether it's the right choice for you now — including reasons to wait or consider something else.

Before you decide

Use this as a shared-decision checklist. The aim is not just “can this be done?”, but whether it is right for you, now, with the risks and alternatives clearly understood.

Myeloma can cause serious complications, and some need urgent treatment — particularly spinal cord compression (new severe back pain with leg weakness, numbness or bladder or bowel problems), high calcium, kidney failure and serious infection. Tell your dentist you take bone-strengthening medicines before any dental work. Be very wary of anyone offering a 'cure' or guaranteeing remission — for most people myeloma is treatable but not curable, and responsible care is led by specialist teams and focused on control and quality of life.

Published figures to discuss

Outcomes in myeloma vary widely by the features of the disease, your age and health, and treatment has improved markedly in recent years, so a single survival figure would be misleading and could be either falsely reassuring or unduly frightening. Myeloma is usually treatable but not curable, and remission length differs greatly between people. Reputable sources such as Myeloma UK, Blood Cancer UK and Cancer Research UK publish general information, which still varies by person. We therefore do not state percentages here; your specialist team can give realistic, individual information, always describing what treatment aims to do rather than guaranteeing it.

These are literature figures, not a personalised prediction. Your own risks and likely benefits depend on your circumstances, your health, and how your care is carried out and followed up.

What happens afterwards

Here, 'recovery' means how diagnosis and treatment unfold and how you respond over time, rather than recovery from a single operation. Myeloma is usually managed in courses of treatment, with periods of remission and monitoring, often over years.

• Tiredness during and after treatment that can take time to improve
• Regular blood and urine tests to track the paraprotein and your response
• Nerve tingling or numbness from some treatments, which is monitored
• Periods of lower immunity, needing care to avoid infection
• Living with the ups and downs of a relapsing condition, for which support is part of good care

Aftercare

• Attend all blood and urine tests and reviews so your response is tracked.
• Take all medicines exactly as prescribed and report side effects such as nerve tingling promptly.
• Stay well hydrated and follow advice to protect your kidneys.
• Watch for signs of infection, such as fever, and follow your team's urgent-contact advice.
• Tell your dentist you take bone-strengthening medicines before any dental treatment.
• Report new or severe back pain, leg weakness or bladder or bowel changes urgently.
• Keep your GP and specialist team informed, and ensure any private care is shared with your NHS team.
• Ask for emotional and practical support, including from Myeloma UK and other charities.

• Blood, urine results, scans and reports gathered
• List of medicines, supplements and other conditions, especially kidney problems
• Note of bone pain, fractures or infection-prone history
• Questions written down, and someone to come with you
• Understanding of what the treatment is aiming to achieve
• Urgent-contact number for fever, severe back pain or weakness
• Dental check arranged before bone-strengthening medicines if advised

⚠ Get urgent help if…

• New severe back pain, especially with leg weakness, numbness, or loss of bladder or bowel control (possible spinal cord compression) — seek help immediately
• A high temperature or feeling very unwell (possible serious infection) — seek urgent help
• Confusion, extreme thirst, drowsiness or passing lots of urine (possible high calcium)
• Passing little or no urine, or marked ankle swelling (possible kidney problems)
• A hot, swollen, painful calf, or sudden breathlessness or chest pain (possible blood clot)
• A new bone pain or a bone that gives way under little force (possible fracture)
• Any symptom your team asked you to report urgently

Who to contact: your clinician, clinic or test provider first (keep their number to hand). For urgent advice when you can't reach them, call NHS 111. In an emergency, call 999.

General guidance — it doesn't replace the specific advice your specialist gives you.

Results & realistic expectations

A good result in myeloma is good control: bringing the myeloma into remission, relieving symptoms such as bone pain, protecting the kidneys and bones, and keeping you well for as long as possible. For most people this is the realistic aim, rather than cure.

Response is measured mainly by the level of the paraprotein and free light chains in the blood and urine, alongside how you feel and any organ damage. A good response can last months or years. Because myeloma usually relapses, your team will explain what your results mean, how you will be monitored, and what would happen when further treatment is needed.

Myeloma is usually a long-term, relapsing condition rather than a one-off illness. Treatment has improved a great deal, and many people live well for years, often through several rounds of treatment and remission. How long each remission lasts varies widely from person to person, depending on the features of the myeloma, the treatment and your health, so your specialist team is the right source for what is realistic in your case.

Related tests, treatments or support

Myeloma care combines anti-myeloma treatment with supportive care: bone-strengthening medicines, kidney protection, treatment of anaemia, pain control, and prevention of infection and blood clots. Diagnosis combines blood and urine tests with a bone marrow test and bone imaging. Some people have radiotherapy to a painful or weakened area of bone. Care is coordinated by the MDT, often alongside clinical trials.

Follow-up & long-term care

Follow-up is long term, with regular blood and urine tests to monitor the paraprotein and free light chains, even during remission, so that relapse is picked up early. You should have regular reviews, a clear plan for what to watch for, a named team to contact, and ongoing supportive care. Results and plans should be shared with your GP.

• Regular blood and urine tests to monitor the myeloma, including during remission
• Ongoing 'maintenance' treatment for a period where this is used
• Bone-strengthening medicines and bone protection, with dental care planned around them
• Kidney protection and treatment of anaemia as needed
• Vaccinations and infection precautions as advised by your team
• Watching for relapse and complications, and knowing who to contact

Repeat, follow-on and what comes next

• Treatment is given in courses, and the combination is changed when the myeloma relapses.
• Maintenance treatment may be used to lengthen remission after initial treatment.
• If one treatment is not tolerated or stops working, a different one is chosen.
• Relapse is expected over time, and the plan evolves with each phase of the disease.

Ask what happens if the result is unclear or needs repeating, and what is included if further tests or follow-up are needed.

What good aftercare looks like

• Care led by a specialist blood-cancer multidisciplinary team, with a clinical nurse specialist as a contact.
• Clear written information on what treatment is aiming for and its risks.
• An urgent-contact route for infection, severe back pain or signs of high calcium or kidney problems.
• Regular monitoring of the paraprotein and of bones and kidneys, with a relapse plan.
• Coordination with the NHS, results shared with your GP, and access to emotional and practical support.

What affects the cost

Costs vary a great deal between people and providers, and we don't publish prices. What matters is understanding what drives the cost and making sure your quote is complete. The main things that affect it:

• Specialist consultations and multidisciplinary team review
• Blood and urine tests, a bone marrow test, and bone imaging
• The treatment itself, which combines several anti-myeloma medicines and sometimes a transplant
• Supportive care, such as bone-strengthening medicines, kidney protection and treatment of anaemia
• Repeat blood and urine tests to monitor the response over time
• Radiotherapy to a painful or weakened bone, where needed
• Long-term follow-up and management of complications and relapse

• Which consultations, tests, the bone marrow test and imaging are included
• How treatment, supportive care and any transplant would be arranged and charged
• Whether care is coordinated with an NHS specialist blood-cancer centre
• Follow-up arrangements and a named contact for urgent problems
• Whether bone and kidney protection and monitoring are included
• Whether results and the plan are shared with your NHS GP and team
• What happens, and what it costs, when the myeloma relapses or a complication occurs

On the NHS? Diagnosis and treatment of myeloma are core NHS specialist care; private care is mainly used for speed, choice or a second opinion, and should be closely coordinated with your NHS team.

You're entitled to your total cost in writing — including reports, follow-up and what happens if the result is inconclusive — before you decide.

Consent traps and marketing red flags

These are not small details. They are often where patients lose choice, time to reflect, or realistic expectations.

Choosing a specialist safely

• Check the specialist is on the GMC Specialist Register for this area.
• Make sure they work at a CQC-registered service, and look for membership of the relevant Royal College or professional body.
• You're entitled to time to consider and to have your questions answered before you agree — the specialist who looks after you should explain it, not a salesperson.
• Be wary of pressure: time-limited offers or deposits taken before you've had time to think are red flags, not bargains.
• You're entitled to your total cost in writing — including any follow-up — before you decide.

How Vuemedics verifies every consultant →

Take this to your consultation. A good specialist will welcome every one of these.

• Do I have active myeloma, smouldering myeloma or MGUS, and what does that mean for me?
• What is my treatment aiming to achieve, and is cure realistic in my case?
• Am I suitable for a stem cell transplant, and what would it involve?
• What are the main risks and side effects of my treatment plan?
• How will my bones and kidneys be protected and monitored?
• What signs of infection, spinal cord compression or relapse should I watch for, and who do I contact urgently?
• Are you on the GMC Specialist Register for this area, and which Royal College or professional body are you a member of?
• Will you be the specialist who carries out my treatment, and who looks after me afterwards?
• What are the risks for someone like me, and how often do your own patients have a problem or need it repeated or redone?
• What does a realistic result look like — and what can this treatment not achieve?
• What are my options, including waiting, doing nothing for now, or choosing a different approach?
• Can I have written information, results and aftercare instructions in a format I can use, including any accessibility or communication support I need?
• What is the total cost in writing, including any follow-ups, and how much time do I have to decide?

Find a verified specialist for myeloma diagnosis and management

Every consultant is GMC-checked and independently reviewed. Search by postcode and distance, or switch to a map. Ordered by rating, relevance and recency — never by who pays.

How we made this page

Medically reviewed by a GMC-registered consultant. Written in plain English, checked against NHS, NICE, GMC and relevant Royal College / specialist-society guidance, and kept under review. No clinic paid to appear on this page, and we publish no pricing. This is general information to help you prepare — it is not a substitute for advice from your own clinician. How we review our guides →

Source hierarchy: UK regulator and NHS/NICE guidance first, then relevant Royal College or specialist-society guidance, then peer-reviewed evidence for procedure-specific figures where available.

Sources & standards: NHS — Multiple myeloma Myeloma UK — information for patients NICE NG35 — Myeloma: diagnosis and management Blood Cancer UK — Myeloma Macmillan Cancer Support — Myeloma Cancer Research UK — Myeloma

Reviews reflect patients' experience of care, not clinical outcomes. For procedure volumes and outcome data see PHIN.

Last medically reviewed 2026-09-21. Spotted something wrong or out of date? Report an error in this guide.